Preprint Article Version 1 This version is not peer-reviewed

Retrospective and Randomized Analysis of Influence and Correlation of Molecular and Clinical Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR

Version 1 : Received: 28 December 2019 / Approved: 29 December 2019 / Online: 29 December 2019 (13:04:12 CET)

A peer-reviewed article of this Preprint also exists.

Salvati, M.; Bruzzaniti, P.; Relucenti, M.; Nizzola, M.; Familiari, P.; Giugliano, M.; Scafa, A.K.; Galletta, S.; Li, X.; Chen, R.; Barbaranelli, C.; Frati, A.; Santoro, A. Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR. Brain Sci. 2020, 10, 91. Salvati, M.; Bruzzaniti, P.; Relucenti, M.; Nizzola, M.; Familiari, P.; Giugliano, M.; Scafa, A.K.; Galletta, S.; Li, X.; Chen, R.; Barbaranelli, C.; Frati, A.; Santoro, A. Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR. Brain Sci. 2020, 10, 91.

Journal reference: Brain Sci. 2020, 10, 91
DOI: 10.3390/brainsci10020091

Abstract

Glioblastoma is a solid, infiltrating and the most frequent highly malignant primary brain tumor. Our aim was to find the prognostic value of mutations of IDH1, MGMT, EGFR, p53, ATRX, Ki67 genes and the correlation between sex, age, presenting with seizures, number of interventions, extent of resection with Overall Survival (OS), Progression Free Survival (PFS) and Karnofsky performance status (KPS) score. A randomized retrospective analysis of 122 patients treated by a single operator at Sapienza University of Rome, was carried out. After surgery patients followed standard treatment Stupp protocol [6]. Exclusion criteria were: patients with primitive brainstem and spinal cord gliomas and patients who underwent partial resections (resection < 90%) and cases of brain biopsy exclusively for diagnostic purposes. Statistical analysis with a simultaneous regression model was carried on by SPSS 25 ® (IBM) program. Results showed statistically significant survival increase in four groups: 1) patients treated with gross total resection (p< 0.03); 2) patients with methylated MGMT promoter (p<0.005); 3) patients with non EGFR amplification or EGFRvIII mutation (p<0.035); 4) mutated IDH1/IDH2 (p<0.0161). Higher survival rates (but not statistically significant) were observed also in patients with: age < 75 years, Ki 67 <10%, lesions in non eloquent areas, ATRX gene mutation and presentation with seizures.

Subject Areas

glioblastoma multiforme; MGMT; IDH1; EGFR; P53; ATRX; Ki67; neurosurgery; oncology; epilepsy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.